216 related articles for article (PubMed ID: 27496275)
21. Utah pharmacists' knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation.
Tolentino V; Unni E; Montuoro J; Bezzant-Ogborn D; Kepka D
J Am Pharm Assoc (2003); 2018; 58(4S):S16-S23. PubMed ID: 29739667
[TBL] [Abstract][Full Text] [Related]
22. Disparities in Provider Recommendation of Human Papillomavirus Vaccination for U.S. Adolescents.
Mohammed KA; Geneus CJ; Osazuwa-Peters N; Adjei Boakye E; Tobo BB; Burroughs TE
J Adolesc Health; 2016 Nov; 59(5):592-598. PubMed ID: 27506278
[TBL] [Abstract][Full Text] [Related]
23. Impact of Virginia's School-Entry Vaccine Mandate on Human Papillomavirus Vaccination Among 13-17-Year-Old Females.
Pierre-Victor D; Page TF; Trepka MJ; Stephens DP; Li T; Madhivanan P
J Womens Health (Larchmt); 2017 Mar; 26(3):266-275. PubMed ID: 27697003
[TBL] [Abstract][Full Text] [Related]
24. Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.
Lai D; Ding Q; Bodson J; Warner EL; Kepka D
Public Health Nurs; 2016 Jul; 33(4):283-94. PubMed ID: 26331614
[TBL] [Abstract][Full Text] [Related]
25. Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012.
Rahman M; McGrath CJ; Hirth JM; Berenson AB
Vaccine; 2015 Jan; 33(5):585-7. PubMed ID: 25529289
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of Adolescents Lacking Provider-Recommended Human Papillomavirus Vaccination.
Krakow M; Beavis A; Cosides O; Rositch AF
J Adolesc Health; 2017 May; 60(5):619-622. PubMed ID: 28073618
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus Vaccine Initiation for Adolescents Following Rhode Island's School-Entry Requirement, 2010-2016.
Thompson EL; Livingston MD; Daley EM; Zimet GD
Am J Public Health; 2018 Oct; 108(10):1421-1423. PubMed ID: 30024803
[TBL] [Abstract][Full Text] [Related]
28. Human Papillomavirus Vaccination Before 13 and 15 Years of Age: Analysis of National Immunization Survey Teen Data.
Bednarczyk RA; Ellingson MK; Omer SB
J Infect Dis; 2019 Jul; 220(5):730-734. PubMed ID: 30657920
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated With Parents' Intent to Vaccinate Adolescents for Human Papillomavirus: Findings From the 2014 National Immunization Survey-Teen.
Mohammed KA; Vivian E; Loux TM; Arnold LD
Prev Chronic Dis; 2017 Jun; 14():E45. PubMed ID: 28595031
[TBL] [Abstract][Full Text] [Related]
30. Going beyond the individual: how state-level characteristics relate to HPV vaccine rates in the United States.
Franco M; Mazzucca S; Padek M; Brownson RC
BMC Public Health; 2019 Feb; 19(1):246. PubMed ID: 30819149
[TBL] [Abstract][Full Text] [Related]
31. Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008-2013).
Hirth J; Kuo YF; Laz TH; Starkey JM; Rupp RE; Rahman M; Berenson AB
Vaccine; 2016 Aug; 34(37):4415-21. PubMed ID: 27435385
[TBL] [Abstract][Full Text] [Related]
32. Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access.
Monnat SM; Rhubart DC; Wallington SF
Matern Child Health J; 2016 Feb; 20(2):315-25. PubMed ID: 26511129
[TBL] [Abstract][Full Text] [Related]
33. Impact of school-entry and education mandates by states on HPV vaccination coverage: Analysis of the 2009-2013 National Immunization Survey-Teen.
Perkins RB; Lin M; Wallington SF; Hanchate AD
Hum Vaccin Immunother; 2016 Jun; 12(6):1615-22. PubMed ID: 27152418
[TBL] [Abstract][Full Text] [Related]
34. Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates.
Suryadevara M; Bonville CA; Cibula DA; Domachowske JB; Suryadevara AC
Vaccine; 2019 Feb; 37(9):1160-1167. PubMed ID: 30691983
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
McClure CA; MacSwain MA; Morrison H; Sanford CJ
Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
[TBL] [Abstract][Full Text] [Related]
36. Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.
Oltean HN; Lofy KH; Goldoft MJ; DeBolt CA
Public Health Rep; 2016; 131(3):474-82. PubMed ID: 27252567
[TBL] [Abstract][Full Text] [Related]
37. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
38. The feasibility and acceptability of a pilot randomized controlled trial testing pharmacy-based HPV vaccine completion.
Koskan A; Zittel ME; Lee C; Sanchez O; Alvarez L; Helitzer DL
Res Social Adm Pharm; 2022 Jun; 18(6):3038-3045. PubMed ID: 34389257
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia.
Aljunid S; Maimaiti N; Nur AM; Noor MRM; Wan Puteh SE
BMC Public Health; 2016 Jan; 16():71. PubMed ID: 26803814
[TBL] [Abstract][Full Text] [Related]
40. State statutes and regulations related to human papillomavirus vaccination.
Hoss A; Meyerson BE; Zimet GD
Hum Vaccin Immunother; 2019; 15(7-8):1519-1526. PubMed ID: 31241406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
